Hong Kong, China

Chiu Yat Patrick Woo

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: The University of Hong Kong, Versitech, Inc.. Active years: 2008-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chiu Yat Patrick Woo. Retrieved from https://idiyas.com/inventor/chiu-yat-patrick-woo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 50.0

 

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2008-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Chiu Yat Patrick Woo: Innovator in Fungal Identification and Coronavirus Research

Introduction

Chiu Yat Patrick Woo is a prominent inventor based in Hong Kong, known for his significant contributions to the fields of fungal identification and virology. With a total of 4 patents, his work has advanced the understanding and treatment of various pathogens.

Latest Patents

One of his latest patents is focused on fungal identification through pattern recognition. This innovative system includes a memory and a processor that executes computer instructions to perform operations. The system incorporates a learning component with trained models that learn pathogenic features of specific fungal species from a variety of stored images. The fungal identifier component utilizes these trained models to assess pathogenic parameters of unidentified fungal species images, ultimately generating an output file that classifies these images based on the determined parameters.

Another notable patent addresses a novel human coronavirus, designated as coronavirus-HKU1. This invention provides the complete genomic sequence of the virus, which was isolated in Hong Kong from a patient with a recent travel history to Shenzhen, China. The virus is classified within the order Nidovirales of the family Coronaviridae, being a single-stranded RNA virus. The patent also includes the deduced amino acid sequences of the complete genome, which are essential for preventing, diagnosing, and treating infections caused by CoV-HKU1. Additionally, it offers immunogenic and vaccine preparations using recombinant and chimeric forms based on the virus's nucleotide sequences.

Career Highlights

Chiu Yat Patrick Woo has worked with esteemed institutions such as The University of Hong Kong and Versitech, Inc. His research and innovations have made a significant impact in the scientific community, particularly in the areas of infectious diseases and pathogen identification.

Collaborations

Throughout his career, Woo has collaborated with notable colleagues, including Kar Pui Susanna Lau and Kwok Yung Yuen. These partnerships have further enhanced his research capabilities and contributions to the field.

Conclusion

Chiu Yat Patrick Woo's innovative work in fungal identification and coronavirus research exemplifies the importance of scientific advancements in public health. His patents reflect a commitment to addressing critical challenges in pathogen detection and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…